| Zacks Company Profile for Tibet Pharmaceuticals Inc. (TBET : OTC) |
|
|
| |
| • Company Description |
| Tibet Pharmaceuticals, Inc operates as a specialty pharmaceutical company focused on the research, development, manufacturing and marketing of modernized traditional Tibetan medicines. The Company conducts its business through its operational entity, YSTP, located in Yunnan Province, China. It develops products in China for promoting health in human respiratory, digestive, urinary and reproductive systems. The Company's product development pipeline includes potential expanded uses of its existing products for additional medical indications and a number of new product candidates that are intended to address significant medical health needs in China. It sells its products principally to distributors in China, who in turn sell them chiefly to hospitals, hospital pharmacies and retail pharmacies. Tibet Pharmaceuticals, Inc is based in China.
Number of Employees: |
|
|
| |
| • Price / Volume Information |
| Yesterday's Closing Price: $0.00 |
Daily Weekly Monthly
 |
| 20 Day Moving Average: shares |
| Shares Outstanding: (millions) |
| Market Capitalization: $ (millions) |
| Beta: |
| 52 Week High: $0.00 |
| 52 Week Low: $0.00 |
| Short Interest Ratio: |
| |
% Price Change |
% Price Change Relative to S&P 500 |
| 4 Week |
% |
% |
| 12 Week |
% |
% |
| Year To Date |
% |
% |
|
|
|
|
| |
| • Address & Contact Information |
| Street Address |
Phone / Fax |
Email Address |
Web URL |
90 JAFFE ROAD ROOM 1701 17/F
-
WANCHAI,K3 -
CHN |
ph: 852-9798-5569
fax: 86-88-7823-2156 |
None |
None |
|
|
| |
| • General Corporate Information |
Officers
Hong Yu - Chairman of the Board of Directors
Taylor Z. Guo - Chief Executive Officer; Director
Sabrina Y. Ren - Chief Financial Officer
Dr. Wenbo Chen - Director
Youhang Peng - Director
|
|
Peer Information
- (-)
- (-)
- (-)
- (-)
- (-)
- (-)
|
|
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-DRUGS
Sector: Medical
CUSIP: G88615102
SIC: 2834
|
|
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: -
Next Expected EPS Date: -
|
|
Share - Related Items
Shares Outstanding:
Most Recent Split Date: (:1)
Beta:
Market Capitalization: $ (millions)
|
|
|
|
|
| |
| • EPS Information |
• Dividend Information |
| Analyst Coverage: No |
Dividend Yield: 0.00% |
| Current Fiscal Quarter EPS Consensus Estimate: $ |
Indicated Annual Dividend: $0.00 |
| Current Fiscal Year EPS Consensus Estimate: $ |
Payout Ratio: |
| Number of Estimates in the Fiscal Year Consensus: |
Change In Payout Ratio: |
| Estmated Long-Term EPS Growth Rate: % |
Last Dividend Paid: NA - $0.00 |
| Next EPS Report Date: - |
|
|
|
| |
